NO983097L - Nisin i kombinasjon med glycerol monolaurat som er aktiv overfor Helicobacter - Google Patents

Nisin i kombinasjon med glycerol monolaurat som er aktiv overfor Helicobacter

Info

Publication number
NO983097L
NO983097L NO983097A NO983097A NO983097L NO 983097 L NO983097 L NO 983097L NO 983097 A NO983097 A NO 983097A NO 983097 A NO983097 A NO 983097A NO 983097 L NO983097 L NO 983097L
Authority
NO
Norway
Prior art keywords
nisin
combination
active against
glycerol monolaurate
against helicobacter
Prior art date
Application number
NO983097A
Other languages
English (en)
Norwegian (no)
Other versions
NO983097D0 (no
Inventor
Peter Blackburn
Beth P Goldstein
Debra J Cook
Original Assignee
Ambi Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ambi Inc filed Critical Ambi Inc
Publication of NO983097D0 publication Critical patent/NO983097D0/no
Publication of NO983097L publication Critical patent/NO983097L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO983097A 1996-01-05 1998-07-03 Nisin i kombinasjon med glycerol monolaurat som er aktiv overfor Helicobacter NO983097L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US987296P 1996-01-05 1996-01-05
PCT/US1997/000186 WO1997025055A1 (fr) 1996-01-05 1997-01-02 Combinaison de nisine et de monolaurate de glycerol agissante contre helicobacter

Publications (2)

Publication Number Publication Date
NO983097D0 NO983097D0 (no) 1998-07-03
NO983097L true NO983097L (no) 1998-09-04

Family

ID=21740219

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983097A NO983097L (no) 1996-01-05 1998-07-03 Nisin i kombinasjon med glycerol monolaurat som er aktiv overfor Helicobacter

Country Status (17)

Country Link
US (1) US5804549A (fr)
EP (1) EP0871469A1 (fr)
JP (1) JP2001517199A (fr)
KR (1) KR19990077069A (fr)
CN (1) CN1117585C (fr)
AU (1) AU720568B2 (fr)
BR (1) BR9706963A (fr)
CA (1) CA2241464C (fr)
CZ (1) CZ208598A3 (fr)
HU (1) HUP9900940A2 (fr)
IL (1) IL124972A0 (fr)
NO (1) NO983097L (fr)
NZ (1) NZ327006A (fr)
PL (1) PL327507A1 (fr)
SK (1) SK91498A3 (fr)
WO (1) WO1997025055A1 (fr)
ZA (1) ZA9610945B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6902738B2 (en) * 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US5834002A (en) 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
US6379651B1 (en) * 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
US6248551B1 (en) * 1997-03-28 2001-06-19 Institut Pasteur Helicobacter aliphatic amidase AmiE polypeptides, and DNA sequences encoding those polypeptides
US5942409A (en) * 1998-07-31 1999-08-24 Byk Gulden Lomberg Chemische Fabrik Gmbh Process for identification of substances modulating ureI dependent mechanisms of Helicobacter pylori metabolism
KR100460173B1 (ko) * 1998-12-11 2004-12-04 겐 코오포레이션 헬리코박터 파일로리 정착 억제제
KR100518263B1 (ko) * 2002-11-21 2005-10-04 학교법인 한마학원 락토코쿠스 락티스 ｎｋ24 (ｋｆｃｃ 11315) 생균을유효성분으로 함유하는 것을 특징으로 하는 위장병 예방및 치료용 조성물
AP2005003346A0 (en) * 2002-12-10 2005-06-30 Biosynexus Inc Topical anti-infective formulations
AU2004270266B2 (en) * 2003-09-09 2011-02-10 3M Innovative Properties Company Concentrated antimicrobial compositions and methods
EP1662873B1 (fr) * 2003-09-09 2016-01-13 3M Innovative Properties Company Compositions antimicrobiennes et procedes
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
AU2005275594A1 (en) * 2004-08-23 2006-03-02 Synergy Pharmaceuticals Pte Ltd Gastric therapies and compositions therefor
US20060229364A1 (en) * 2005-03-10 2006-10-12 3M Innovative Properties Company Antiviral compositions and methods of use
US20060204558A1 (en) * 2005-03-10 2006-09-14 Kantner Steven S Antimicrobial pet wipes and methods
EP3025704B1 (fr) 2005-03-10 2019-01-16 3M Innovative Properties Company Procédés de réduction de contamination microbienne
WO2006099358A2 (fr) 2005-03-10 2006-09-21 3M Innovative Properties Company Compositions antimicrobienes et methodes s'y rapportant
WO2006099325A2 (fr) 2005-03-10 2006-09-21 3M Innovative Properties Company Methodes destines au traitement d'infections de l'oreille
MY140578A (en) * 2005-12-07 2009-12-31 Malaysian Agricultural Res And Dev Inst Mardi Modified coconut oils with broad antimicrobial spectrum
US20080075793A1 (en) * 2006-09-21 2008-03-27 Dunshee Wayne K Antiviral compositions and methods of use
CN102100687B (zh) * 2009-12-17 2012-10-03 美利泰格诊断试剂(嘉兴)有限公司 聚赖氨酸在制备杀灭口腔螺旋杆菌药物的应用
KR100980254B1 (ko) * 2010-02-02 2010-09-06 주식회사 페모지아 위염, 궤양의 원인이 되는 헬리코박터 파일로리균 살균을 위한 폴리라이신과 글리세롤 모노라우레이트를 함유하는 조성물
CN103636633B (zh) * 2013-11-26 2015-12-02 广西安泰化工有限责任公司 淀粉作为农药填料的应用
US20160095876A1 (en) 2014-10-01 2016-04-07 Rochal Industries, Llp Composition and kits for inhibition of pathogenic microbial infection and methods of using the same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485029A (en) * 1984-03-19 1984-11-27 Minnesota Mining And Manufacturing Company Disinfecting method and compositions
US5135910A (en) * 1988-06-22 1992-08-04 The Public Health Research Institute Of The City Of New York Nisin compositions for use as enhanced, broad range bactericides
US5217950A (en) * 1988-06-22 1993-06-08 Applied Microbiology, Inc. Nisin compositions for use as enhanced, broad range bactericides
US5260271A (en) * 1988-06-22 1993-11-09 Applied Microbiology, Inc. Nisin compositions for use as enhanced broad range bactericides
HU204980B (en) * 1988-06-22 1992-03-30 New York Health Res Inst Agents containing bactericidal of lanthionine content and method for producing same
US5304540A (en) * 1988-06-22 1994-04-19 Applied Microbiology, Inc. Pharmaceutical bacteriocin compositions and methods for using the same
US4980163A (en) * 1989-03-01 1990-12-25 Public Health Research Institute Of The City Of New York Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection
US5328846A (en) * 1989-08-03 1994-07-12 The Penn State Research Foundation Method for removing exogenous deposits from hydrophilic contact lenses
GB9108080D0 (en) * 1991-04-15 1991-06-05 Smithkline Beecham Plc Pharmaceutical composition
DK0589893T3 (da) * 1991-04-15 1996-09-09 Applied Microbiology Inc Anvendelse af et bakteriocin som antimikrobielt middel til fremstilling af et lægemiddel til behandl ing af maveforstyrrelser forbundet med helicobacter pylori
JPH08504401A (ja) * 1992-10-29 1996-05-14 デネッケ，ライナー 消化管疾患の治療および特に予防用製剤

Also Published As

Publication number Publication date
JP2001517199A (ja) 2001-10-02
PL327507A1 (en) 1998-12-21
US5804549A (en) 1998-09-08
CA2241464C (fr) 2001-10-16
CN1207045A (zh) 1999-02-03
AU1572197A (en) 1997-08-01
KR19990077069A (ko) 1999-10-25
CZ208598A3 (cs) 1998-12-16
HUP9900940A2 (hu) 1999-07-28
SK91498A3 (en) 1999-05-07
WO1997025055A1 (fr) 1997-07-17
NO983097D0 (no) 1998-07-03
EP0871469A1 (fr) 1998-10-21
ZA9610945B (en) 1997-06-30
IL124972A0 (en) 1999-01-26
CN1117585C (zh) 2003-08-13
BR9706963A (pt) 1999-05-04
CA2241464A1 (fr) 1997-07-17
AU720568B2 (en) 2000-06-08
NZ327006A (en) 2000-10-27

Similar Documents

Publication Publication Date Title
NO983097L (no) Nisin i kombinasjon med glycerol monolaurat som er aktiv overfor Helicobacter
NO982311L (no) Sammensetninger og fremgangsmÕter for forhindring og behandling av oral muscositt
ATE207342T1 (de) Gegen hautalterung wirksame stoffe oder wirkstoffkombinationen und zubereitungen
DK0751789T3 (da) Gel til behandling af hudsygdomme og til desinfektion af huden
DK47189A (da) Bredspektret konserveringsmiddel med synergistisk biocidvirkning
ID29393A (id) Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah
AR020055A1 (es) Una composicion farmaceutica o cosmetica que contiene una sustancia de esmalte activa, usos de dicha composicion y un metodo para preparar la misma.
ATE220918T1 (de) Matrixprotein enthaltende zusammensetzungen zur wundheilung
ATE218868T1 (de) Hustenhemmende, theobromine enthaltende zusammensetzungen
NO953995L (no) Ionenolymere som anthelmintica i dyr
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
ATE169445T1 (de) Verwendung von gelformulierungen als beizmittel
ATE49115T1 (de) Haarbehandlungsmittel.
NO984760L (no) Anvendelse av en osmolytt ved behandling av effekter forÕrsaket av en infeksjon, en inflammasjon eller en immundysfunksjon
AU2001259801A1 (en) 3-methoxybenzyl thiourea derivatives and improved lipid compositions containing same
DE69902520D1 (de) Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden
FI932654A0 (fi) Hydroxamsyraderivat, som hindrar lipoxigenas
DE69808663T2 (de) Neomycin/disaccharid wässerige lösung zur behandlung von enteroclysis bei hepatischer enzephalopathie
PT1313500E (pt) Associacoes de dalfopristina/quinupristina com o cefpirome
FI884041A (fi) Desinfiointikoostumus stafylokokkien tappamiseksi

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application